New device zaps lung tumors through a scope before surgery

NCT ID NCT06689488

Recruiting now Disease control Sponsor: Creo Medical Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device that uses microwave energy to destroy lung tumors during a bronchoscopy, before the patient has surgery to remove the tumor. The goal is to see if the device is safe and works well in 30 people with confirmed lung cancer who are already scheduled for surgery. The researchers will check for serious side effects and measure how well the device destroys the targeted tissue.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Microwave ablation device (MicroBlate™ Flex AB1)
What this could lead to: If it works, this could lead to a less invasive way to destroy lung tumors using a bronchoscope, potentially reducing the need for more extensive surgery.
What could go wrong: This is a very early, small trial with only 30 participants, so results may not apply to everyone. The procedure involves risks like bleeding or damage to nearby tissue, and the device may not work as expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

Amsterdam University Medical Centres, Location AMC, Meibergdreef 9
RECRUITING

Amsterdam, The Netherlands, 1105 AZ, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.